Not logged in
  Home   Markets   Shares   Funds   Portfolio   Toolbox   Charting   Alerts   Directory   
 Admin   

Tue 18 Nov 2003, 10:33 Network Healthcare Holdings Limited - Audited Grou
Network Healthcare Holdings Limited - Audited Group Results For The Year Ended 
Release Date: 18/11/2003 07:30:02      Code(s): NTC 
NETWORK HEALTHCARE HOLDINGS LIMITED - AUDITED GROUP RESULTS FOR THE YEAR ENDED  
30 SEPTEMBER 2003                                                               
NETWORK HEALTHCARE HOLDINGS LIMITED                                             
The Integrated Healthcare Network                                               
Registration number 1996/008242/06                                              
Incorporated in the Republic of South Africa                                    
JSE share code: NTC                                                             
ISIN code: ZAE000011953                                                         
("Netcare" or "the Company")                                                    
Growing with people                                                             
AUDITED GROUP RESULTS FOR THE YEAR ENDED 30 SEPTEMBER 2003                      
*    Revenue up 24,9%                                                           
     (Organic 17,9%)                                                            
*    EBIT up 30,0%                                                              
*    Headline earnings per share up 25,1%                                       
*    Capital distribution up 30,4%                                              
*    Market share growth across all divisions                                   
*    Netpartner completes Integrated Healthcare strategy                        
*    Netcare International establishes UK platform                              
*    Netcare receives highest quality rating                                    
INTRODUCTION                                                                    
The year under review has been characterised by three key factors:              
1.   GROWTH                                                                     
As a result of the Group"s focused integrated healthcare strategy, Netcare 
     has experienced significant organic growth in all of the primary healthcare
     businesses. The commitment of management, as well as the dedication and    
     professionalism of medical professionals and staff has once again yielded  
significant returns for all stakeholders.                                  
2. DEVELOPMENT                                                                  
     Platforms have been established in three pivotal areas of Netcare"s defined
     strategy to ensure sustainable growth for the Group:                       
*    Completion of the healthcare value and supply chain through the development
     and formation of Netpartner Investments Limited ("Netpartner");            
*    Initiation of the Public Private Partnership with the Free State Health    
     Department; and                                                            
*    Progression of the International Expansion plans with two potential major  
     contracts to provide quality care to patients under the National Health    
     Service ("NHS") in the United Kingdom.                                     
3.   LEADERSHIP STRATEGIES                                                      
During the year Netcare made key enhancements to its stated value          
     disciplines;                                                               
*    Operational excellence - Specific management interventions have resulted in
     improved margins in the majority of the Group"s businesses.                
*    Customer intimacy - Together with the overwhelming support for Netpartner, 
     an additional 95 specialists have relocated to Netcare facilities, and a   
     further 104 general practitioners and dentists have contracted with        
     Medicross for management and administration services.                      
*    Best and safest product - Independent research by TWIG S.A. has found that 
     Netcare achieved the highest quality ratings in its peer group. In         
     addition, comprehensive patient satisfaction questionnaires completed by   
     over 1 million patients across the operational units have reflected ratings
in excess of 90%.                                                          
     These three leadership strategies, together with fanatical attention to    
     detail and the Group"s commitment to investing purposefully in businesses  
     which directly or indirectly support the core hospital business, will      
ensure that Netcare succeeds in its objective of generating sustainable    
     shareholder wealth.                                                        
     Significantly, the year has not been without its challenges. The dynamic   
     nature of the healthcare industry as well as growing pressure on the Public
Sector Health Services has resulted in additional requirements being placed
     on the Group in terms of its Corporate and Social commitments.             
     Encouragingly though, it is in the face of these challenges that the Group 
     has adapted and evolved to yield satisfying results.                       
FINANCIAL OVERVIEW                                                              
OPERATING RESULTS                                                               
Netcare"s Revenue for the year increased by 24,9% to R6012,6 million (2002:     
R4812,3 million), with the Group"s interests in diagnostics and imaging         
administration and management services, including its 50% interest in the Ampath
Trust ("Ampath") (collectively referred to as "Netcare Diagnostics") being      
proportionately consolidated for the first time. Organic growth in Revenue      
amounted to 17,9%. EBITDA margins increased to 20,1% (2002: 19,6%), while EBIT  
margins have increased to 16,9% (2002: 16,3%).                                  
Headline earnings per share ("HEPS") increased by 25,1% to 45,9 cents per share 
(2002: 36,7 cents per share). Since 1997, the 6-year compound annual growth in  
HEPS has amounted to 36,2%.                                                     
The results have led to a return on ordinary shareholders" equity ("ROE") of    
25,0% which, after adjustments for past goodwill write-offs, amounts to a more  
modest 19,3%.                                                                   
SEGMENTAL REPORTING                                                             
REVENUE (RM)              EBITDA (RM)                          
                      2003     2002    %    2003     2002   %                   
Hospitals             4 625,1  3 992,6 15,8 1 070,9  869,5  23,2                
Other businesses      1 387,5  1 114,7 24,5 139,5    127,5  9,4                 
Medicross             569,3    489,6   16,3 63,9     52,8   21,0                
Netcare Diagnostics   324,5    295,0   10,0 67,7     54,1   25,1                
Traumanet             219,3    163,0   34,5 (32,2)   8,0    NA                  
International         59,1     31,6    87,0 6,2      (1,5)  NA                  
Other                 215,3    135,5   58,9 33,9     14,1   140,4               
Total                 6 012,6  5 107,3 17,7 1 210,4  997,0  21,4                
                      EBIT  (RM)                                                
                      2003     2002    %                                        
Hospitals             923,7    741,6   24,6                                     
Other businesses      94,2     86,2    9,3                                      
Medicross             42,1     30,8    36,7                                     
Netcare Diagnostics   58,8     44,7    31,5                                     
Traumanet             (33,0)   5,1     NA                                       
International         4,8      (1,6)   NA                                       
Other                 21,5     7,2     198,6                                    
Total                 1 017,9  827,8   23,0                                     
The Group has several business units with the South African hospital division   
being its core business. An analysis of Revenue, EBITDA and EBIT for certain of 
the Group"s larger business units is set out below.                             
The comparative figures have been adjusted on a pro-forma basis to take account 
of Netcare Diagnostics. These investments are now accounted for as joint        
ventures and are proportionately consolidated, whereas in the prior year they   
were largely accounted for as associates. This change has no effect on earnings.
Whilst the core hospital business, which represents 76,9% and 88,5% of Group    
Revenues and EBITDA respectively, reported solid results for the period under   
review, the reported loss at Traumanet was extremely disappointing.             
BORROWINGS AND FINANCING COSTS                                                  
Financing costs increased to R157,6  million (2002: R104,7 million) due         
primarily to the cash resources being cost effectively applied in reducing      
creditor financing and the Netcare Diagnostics inclusion. Material cash flows   
during the period included: investment in the Group"s capital expenditure       
programme amounting to R425,1million (2002: R366,1million), share repurchase of 
R79,8 million, capital distributions of R183,1million (2002: R137,4million), and
the net cash inflow of R106million on the Netpartner transaction.               
Notwithstanding, interest cover remains at a satisfactory 6,5 times (2002: 7,5  
times). The current declining interest rate climate, with rates having been     
significantly reduced during the past six months, bodes well for reduced finance
charges in 2004.                                                                
These factors, as well as the proportionate consolidation of Netcare            
Diagnostics, have contributed to net interest-bearing debt increasing to R899,4 
million (2002: R752,1 million) and net debt:equity ratio reducing to 28,7%      
(2002: 34,3%).                                                                  
CREDIT RATING                                                                   
During the year Netcare achieved a credit rating upgrade by Global Credit       
Ratings to A1 for its short-term debt and A (previously A-) in respect of its   
long-term debt.                                                                 
ACCOUNTING POLICIES                                                             
The financial statements are prepared in accordance with and comply with South  
African Statements of Generally Accepted Accounting Practice. The principal     
accounting policies as set out in the 2002 annual report have been consistently 
applied, except for the change in policy as detailed below.                     
During the year the Group applied AC133 relating to the Recognition and         
Measurement of financial instruments.  The Group has elected to account for the 
changes in fair value of financial instruments regarded as "available for sale" 
through changes in equity and not through the income statement.  The adoption of
AC133 has resulted in an increase in opening reserves of R46,1 million, and a   
positive impact on equity in the current year to the extent of R118,6 million.  
AUDIT REPORT                                                                    
The joint auditors, Grant Thornton and Fisher Hoffman PKF (Jhb) Inc. have issued
their opinion on the Group"s financial statements for the year ended 30September
2003. A copy of their unqualified report is available for inspection at the     
Company"s registered office.                                                    
JSE SECURITIES EXCHANGE REQUIREMENTS                                            
The final announcement has been prepared in accordance with the listing         
requirements of the JSE Securities Exchange South Africa.                       
SIGNIFICANT CORPORATE TRANSACTIONS                                              
During the year the Group implemented a specific repurchase of 52,7 million     
Netcare shares for an effective consideration of R79,8 million.  Shareholders   
are referred to the circular and announcement dated 12 December 2002 and 27     
January 2003 respectively for further INFORMATION ON THIS REPURCHASE.           
At the end of the financial year a transaction between the Group and Netpartner 
was implemented in terms of which the Group sold a 20% stake in Medicross and   
issued 100 million Netcare shares for a total consideration of R324 million to  
Netpartner, while Netcare invested R218 million in Netpartner in consideration  
for a 48,4% stake.                                                              
OPERATIONAL REVIEW                                                              
The Netcare Group and its associated divisions demonstrated significant organic 
growth for the period under review. Despite pressure on margins due to improved 
staff benefits; lower inflation and the impact of a strengthening Rand on the   
hospital division, profitability improved across the Group with the exception of
Traumanet. The Group"s strong performance was largely underpinned by good growth
in market share and effective buying strategies introduced at the end of 2002.  
Patient care quality continues at satisfactory levels and remains a high        
priority as a differentiator going forward.                                     
CORE HOSPITAL NETWORK                                                           
NETCARE HOSPITAL DIVISION                                                       
*    The hospital division has shown increased market share and recorded strong 
     organic growth in Revenue of 15,4%. Inflation and case mix accounted for   
approximately 11,2%. The out of pocket Revenue continues to increase       
     reflecting the growing need by patients for first world quality healthcare 
     on demand.                                                                 
*    The key activity indicators of patient days, admissions and maternity cases
increased by 3,5%; 8,6% and 7,4% respectively.                             
*    EBITDA margins increased significantly from 21,8% in 2002 to 23,2% in 2003,
     reflecting the implementation of alternative reimbursement methods, the    
     performance highlighted above and further operational efficiency gains.    
*    The hospital infrastructure was bolstered by the realignment and improved  
     utilisation of more than 150 beds, all forming part of the national capital
     expenditure programme incurred in upgrading and expanding certain of the   
     Group"s full service acute care hospitals. As these became effective at    
various stages during the year, the benefits are likely to be realised more
     fully in 2004.                                                             
SUPPLY CHAIN                                                                    
TRAUMANET                                                                       
Traumanet (the owner of the Netcare 911 brand) offers fully integrated, world-  
class pre-hospital emergency medical assistance, evacuation by road or air and  
telephonic medical advisory services in South Africa and the rim countries.     
The number of insured principal members grew 64% year-on-year, rising from 5,2  
million to over 8,5 million by September 2003 and the number of emergency cases 
attended increased by 50% over last year to a record of 133 848 (1 case every 4 
minutes).                                                                       
Increased brand awareness (082 911) as well as the with lack of resources and   
budgetary constraints in the state sector resulted in indigent, non paying      
patient transfers increasing by 79% during the year. This reflects 24% of total 
response calls and translates into a loss of more than R39million. The Board    
however considers this to be a humane and important responsibility and will     
continue this practice. To date, while no agreement has been reached to recover 
these losses from the Provinces, Netcare has deemed it prudent to write the     
above amounts off as irrecoverable.                                             
Despite the higher workload, overall service levels remained high. The first    
emergency ambulance was on scene within twelve minutes in at least 90% of the   
time-critical (Priority 1, red code) cases across metropolitan regions. TWIG SA 
market research, conducted monthly among our user base, revealed positive       
service satisfaction indices and overall experience ratings in excess of 92%.   
The disappointing performance was substantially due to increased services to    
indigents, administration issues and exponential growth in market share which   
outstripped infrastructure and controls.  The division is receiving the         
necessary attention with a new management team in place.                        
NETCARE INTERNATIONAL                                                           
The NHS has committed to increase its healthcare spend to GBP87 billion over the
next five years, which includes outsourcing of certain services.                
With three successful waiting lists having been completed and the fourth        
currently underway, Netcare International is developing a sustainable working   
relationship with the NHS. Netcare is also the preferred bidder on two          
Independent sector Treatment Centre contracts with the NHS. These contracts each
span over five years with guaranteed patient volumes and a combined contract    
value of approximately GBP113,8 million.                                        
Importantly, this expansion represents a valuable human retention strategy for  
Netcare by allowing staff to work on a rotation basis in the UK and return to   
employ their skills and expertise into their respective hospitals.              
NETPARTNER                                                                      
Netcare"s strategy has always been to develop an integrated healthcare delivery 
model and to be the lowest cost provider of quality healthcare.                 
Netpartner is key to achieving this end with the overall intention of ensuring  
that private healthcare will be more sustainable, affordable and accessible,    
while offering the new SA a new healthcare solution.  The most encouraging      
aspect of Netpartner has been the support of healthcare professionals for its   
primary objective to bring "BETTER CARE TO MORE PEOPLE", and will certainly;    
*    provide a meaningful foundation to increase the number of insured lives;   
*    offer a comprehensive solution for those Public Sector employees who are   
     currently uninsured; and most importantly,                                 
*    be a positive advance in retaining quality healthcare professionals in the 
country.                                                                   
The private placement of Netpartner shares was over-subscribed with more than   
4000 General Practitioners and Specialists and 2 200 Dentists, Pharmacists,     
Optometrists and other shareholders investing (32% representing individuals from
previously disadvantaged communities). Netpartner is well capitalised and       
favourably positioned to roll out its business development strategy with        
approximately R600 million in assets (includes R100 million in cash resources). 
As at the date of this announcement the ruling share price was trading at a 40% 
premium to the offer price.                                                     
ADMINISTRATION, LOGISTICAL AND SUPPORT SERVICES                                 
Netcare has invested in and developed a core competency in providing            
administrative, logistical and support services to a range of healthcare        
providers.                                                                      
MEDICROSS                                                                       
Medicross has successfully increased its management and administration services 
to more than 92 general practitioner and dental practices (2002: 60) across     
South Africa.                                                                   
The financial turnaround of Medicross since its acquisition by Netcare in 2001  
has continued during the reporting period. The organisation has outperformed    
expectations by posting a 21,0% increase in EBITDA to R63,9 million (2002: R52,8
million) and a 16,3% increase in Revenue to R569,3 million (2002: R489,6        
million).                                                                       
Patient visits grew by 16,3% to 2,8 million for the period, with dispensed      
prescriptions rising by 11,9%. The use of generics has increased from 32% to 39%
over the period. In addition, the number of capitated lives managed by the      
organisation grew during the year to over 40 000 across nine medical aid        
schemes.  These figures are indicative of the growth and operational            
efficiencies experienced across the organisation.                               
NETCARE DIAGNOSTICS                                                             
Netcare"s increased involvement during the year with the management and         
administration of diagnostic and imaging practices as well as Ampath, has       
resulted in EBITDA increasing to R67,7 million (Pro forma 2002: R54,1 million)  
with EBITDA margins at 20,9% (Pro forma 2002: 18,3%). The professional practices
served by Ampath have gained further market share, with the number of           
requisitions growing by more than 3,7% year-on-year.                            
Ampath remains the only pathology management group in South Africa with a truly 
national footprint.                                                             
JOINT INVESTMENTS WITH COMMUNITY HOSPITAL GROUP ("CHG") (BEE Partner)           
The Group"s strategy towards the empowerment of previously disadvantaged        
communities has proven successful with the performance of Community Hospital    
Group ("CHG") meeting all expectations. CHG generates Revenue on an aggregated  
basis in excess of R250 million per annum with an EBIT margin of 16,0%.         
The prospects for this Group are encouraging given the opportunities within     
healthcare in SA and given Netcare and Community"s commitment towards working   
with Government on a national scale in providing meaningful healthcare          
assistance and solutions.                                                       
OTHER SUPPLY SIDE BUSINESSES                                                    
NATIONAL RENAL CARE ("NRC")                                                     
NRC remains the leading Total Renal Disease Management Company in the private   
renal dialysis market in South Africa, focusing on cost effective quality renal 
care and outcome management, benchmarked against international standards. Six   
additional dialysis units were opened during the year bringing the total number 
of NRC units in southern Africa to 38. Revenue and EBIT grew by 19,2% and 19,6% 
respectively versus the prior year.                                             
CLINICAL PARTNERS                                                               
Clinical Partners healthcare managed care model continues to deliver excellent  
results, as evidenced by the Netcare Medical Scheme. The scheme"s reserves      
exceed 30% with contribution increases for 2004 the lowest in the industry at   
less than 8%, despite paying participating specialists above the recommended    
tariff. The expertise developed by Clinical Partners, together with the         
Medicross capitated product, will be utilised by Netpartner to develop and      
manage new products.                                                            
SAA-NETCARE TRAVEL CLINICS                                                      
There are now eleven retail SAA-Netcare Travel Clinics on a national basis.     
Revenue was up 44,3% which includes a growth strategy around large scale site   
tenders for occupational health.                                                
CORPORATE CITIZENSHIP                                                           
The Group provides support to disadvantaged communities for humanitarian and    
social endeavours. In the past year more than R60 million was applied in this   
regard.                                                                         
Walter Sisulu Cardiac Institute for Africa ("WSCIA")                            
Following on the relocation of Dr Kinsley and his team to Sunninghill hospital  
in January 2003 the WSCIA has been established as a cardiology centre of        
excellence specialising in paediatric cardiac medicine. The WSCIA was officially
opened by former president Nelson Mandela with a Section 21 company (Not for    
profit) established to raise an apply funds to, inter alia, reduce mortality    
associated with congenital heart disease for all the children across Africa.    
GROWING WITH PEOPLE                                                             
The Netcare Group increased its spend on training to more than R84,0 million by 
expanding training and development at all levels in the organisation to improve 
service levels; encourage personal growth; meet SETA objectives and position the
Group favourably for expansion. As an additional spend and focus was motivated  
by the SETA programme, which grants did not all materialise, an unexpected under
recovery of approximately R8,6 million resulted.                                
The Goldcare programme continues to be a successful staff initiative in         
maintaining high quality care with new modules continuously being introduced.   
In addition, Netcare was once again voted one of the top 40 companies to work   
for in South Africa, a commendation the Group is extremely proud of.            
PROSPECTS                                                                       
With the solvency of Medical Aid Schemes being better than ever and single digit
provider medical inflation anticipated to be the lowest in a decade, the private
healthcare sector is well positioned to benefit from increasing numbers of      
insured lives.                                                                  
Several new legislative changes will be implemented with single exit pricing on 
ethicals due to be finalised by May 2004.                                       
The inefficient fee for service model is gradually being replaced with          
alternative reimbursive models which Netcare has pioneered with great success   
through its capitated products in Medicross and the integrated model via        
Clinical Partners.                                                              
In partnership with Netpartner healthcare professionals, the Group can now offer
a full range of healthcare services to almost 80% of the insured population on a
national basis. This favourable positioning will see the development of numerous
preferred provider products in the future with the ultimate objective of making 
private healthcare more affordable to more people of South Africa.              
Netcare remains confident that as with other healthcare reforms introduced over 
the past seven years, it will adapt its model and continue to provide acceptable
shareholder returns without compromising on its delivery of exceptional service 
to its patients and customers.                                                  
Accordingly, in the absence of any unforeseen circumstances, the Group believes 
that its business model is balanced and sound to continue to generate           
satisfactory increases in earnings in the year ahead and meaningful returns for 
all stakeholders.                                                               
CHANGES IN DIRECTORATE                                                          
Mrs SV Zilwa and Mr P Warrener resigned as non-executive and executive directors
with effect from 17 January and 23 September 2003, respectively.                
CAPITAL DISTRIBUTIONS                                                           
In accordance with the authority given to the directors by way of an ordinary   
resolution passed on 24 January 2004, the Board of directors has declared a     
final capital distribution out of share premium of 9,0 cents per ordinary share,
payable to shareholders recorded in the register of the Company as at Friday, 6 
February 2004.  Taken together with the interim distribution of 6,0 cents per   
share, the total distribution paid and to be paid in respect of the 2003        
financial year amounts to 15,0 cents (2002: 11,5 cents) per ordinary share, an  
increase of 30,4% over the prior period.                                        
In compliance with the requirements of STRATE the following dates are           
applicable:                                                                     
                                                  2004                          
Last date to trade "CUM" the capital                                            
distribution ("LDT")                              Friday, 30 January            
Trading commences "EX" the capital                                              
distribution                                      Monday, 2 February            
Record date                                       Friday, 6 February            
Date of payment                                   Monday, 9 February            
Share certificates may not be dematerialised or rematerialised between Monday, 2
February 2004 and Friday, 6 February 2004, both dates inclusive.                
By order of the Board                                                           
Michael I Sacks      Dr Jack Shevel            Sandton                          
Chairman             Chief Executive Officer   17 November 2003                 
GROUP BALANCE SHEET                                                             
                                           Audited      Audited                 
2003         2002                    
                                           (Rm)         (Rm)                    
Assets                                                                          
Non-current assets                                                              
Property, plant and equipment              2 704,0      2 413,0                 
Intangible assets                          169,6        89,8                    
Investments and loans                      488,6        181,6                   
Deferred taxation                          41,5         41,5                    
Other financial assets                     426,7        183,1                   
Total non-current assets                   3 830,4      2 909,0                 
Current assets                                                                  
Inventories                                376,5        233,6                   
Accounts receivable                        1 159,9      854,0                   
Total current assets                       1 536,4      1 087,6                 
Total assets                               5 366,8      3 996,6                 
Equity and liabilities                                                          
Ordinary shareholders" equity              3 061,6      2 187,7                 
Minority interest                          71,8         7,7                     
Total shareholders" equity                 3 133,4      2 195,4                 
Net interest-bearing debt                  899,4        752,1                   
Non-current liabilities                                                         
Deferred taxation                          268,1        128,6                   
Current liabilities                                                             
Accounts payable                           871,1        749,7                   
Vendors for acquisition                    -            13,3                    
Current taxation                           194,8        157,5                   
Total current liabilities                  1 065,9      920,5                   
Total equity and liabilities               5 366,8      3 996,6                 
Net equity per share (cents)               200,0        150,6                   
GROUP INCOME STATEMENT                                                          
                              Audited      Audited                              
                              2003         2002         %                       
(Rm)         (Rm)         change                  
Revenue                       6 012,6      4 812,3      24,9                    
Operating profit before                                                         
depreciation and amortisation                                                   
(EBITDA)                      1 210,4      942,9        28,4                    
Depreciation and amortisation 192,5)       (159,8)                              
Operating profit (EBIT)       1 017,9      783,1        30,0                    
Net finance charges           (157,6)      (104,7)                              
Profit before taxation        860,3        678,4                                
Taxation                      (202,5)      (170,6)                              
Profit after taxation         657,8        507,8        29,5                    
Attributable earnings                                                           
of associates                 0,4          20,5                                 
Profit after taxation                                                           
including associates          658,2        528,3                                
Minority interest             (1,1)        (2,3)                                
Earnings attributable to                                                        
ordinary shareholders         657,1        526,0        24,9                    
EARNINGS RECONCILIATION                                                         
                              Audited      Audited                              
2003         2002         %                       
                              (Rm)         (Rm)         change                  
Attributable earnings         657,1        526,0                                
Goodwill amortised            6,9          3,9                                  
Profit on sale of investment  (8,8)        -                                    
Headline earnings             655,2        529,9        23,6                    
Earnings per share (cents)                                                      
Headline - basic              45,9         36,7         25,1                    
- fully diluted               43,8         34,8         25,9                    
Attributable - basic          46,0         36,4         26,4                    
- fully diluted               43,9         34,5         27,2                    
Cash equivalent earnings per                                                    
share (cents)                 58,7         49,6         18,3                    
STATEMENT OF CHANGES IN SHAREHOLDERS" EQUITY                                    
                                           Audited      Audited                 
                                           2003         2002                    
(Rm)         (Rm)                    
Ordinary shareholders" equity at                                                
beginning of year                          2 187,7      1 580,2                 
Adjustment to opening balance on adoption                                       
of AC 133                                  46,1         -                       
Restated balance                           2 233,8      1 580,2                 
Earnings attributable to ordinary                                               
shareholders                               657,1        526,0                   
Fair value surplus on available for sale                                        
investments net of tax                     118,6        -                       
Currency translation reserves              (7,9)        -                       
Issue of shares                            315,5        218,9                   
Share buyback                              (79,8)       -                       
Capital distributions                      (183,1)      (137,4)                 
Other                                      7,4          -                       
Balance at end of year                     3 061,6      2 187,7                 
ABRIDGED GROUP CASH FLOW STATEMENT                                              
                                           Audited      Audited                 
                                           2003         2002                    
                                           (Rm)         (Rm)                    
Cash generated from operations             1 189,0      941,2                   
Working capital movements                  (310,2)      (116,9)                 
Cash generated from operating activities   878,8        824,3                   
Net finance charges                        (157,6)      (104,7)                 
Taxation paid                              (153,6)      (130,5)                 
Cash inflow from operating activities      567,6        589,1                   
Capital distributions paid                 (183,1)      (137,4)                 
Net cash retained                          384,5        451,7                   
Other investing and financing activities   (455,4)      (525,6)                 
Capital expenditure                        (425,1)      (366,1)                 
Net investment in businesses               (255,8)      (167,6)                 
Share buyback by subsidiary                (79,8)       -                       
Net equity movements                       305,3        8,1                     
                                           (70,9)       (73,9)                  
Net debt assumed on consolidation of                                            
businesses                                 (76,4)       (1,0)                   
Movement in net interest-bearing debt      (147,3)      (74,9)                  
Net interest-bearing debt                                                       
At beginning of year                       (752,1)      (677,2)                 
At end of year                             (899,4)      (752,1)                 
KEY FINANCIAL INFORMATION                                                       
                                           Audited      Audited                 
                                           2003         2002                    
Ordinary shares (millions)                                                      
In issue                                   1 530,7      1 452,9                 
Weighted average number of shares          1 428,8      1 444,8                 
Fully diluted weighted average number                                           
of shares                                  1 496,5      1 523,9                 
Distributions                                                                   
Capital distributions (cents per share)                                         
Interim                                    6,0          4,5                     
Final                                      9,0          7,0                     
Other salient features                                                          
EBITDA margin (%)                          20,1         19,6                    
EBIT margin (%)                            16,9         16,3                    
Interest cover (times)                     6,5          7,5                     
Effective taxation rate (%)                23,6         25,0                    
Operating profit return on net assets (%)  29,2         30,4                    
Return on ordinary shareholders" equity (%)25,0         28,1                    
Debt:equity ratio (%)                      28,7         34,3                    
Capital expenditure for the year (Rm)      425,1        366,1                   
Capital commitments (Rm)                   185,4        206,4                   
This is a summarised commentary and results announcement. A full annual report  
will be published on the Internet and a hard copy will be mailed to shareholders
on or about 12 December 2003. The annual general meeting will be held on 23     
January 2004 and notice thereof will be given in the annual report. The results 
can be viewed on the website www.netcareinvestor.co.za                          
Registered office - 76 Maude Street, Sandton 2196 (Private Bag X34, Benmore     
2010).  Transfer secretaries - Ultra Registrars (Pty) Limited, 11 Diagonal      
Street, Johannesburg 2001 (PO Box 4844, Johannesburg 2000).  Sponsor - Merrill  
Lynch South Africa (Pty)Limited.                                                
Executive directors: MI Sacks (Chairman), Dr J Shevel (Chief Executive Officer),
Dr RH Friedland (Chief Operating Officer), SR Favish (Chief Financial Officer), 
Dr RH Bush, IM Davis,  Dr I Kadish, PJ Lindeque, Dr C Rossolimos, N Weltman.    
Non-executive directors: Dr APH Jammine, JM Kahn, HR Levin, Dr JA van Rooyen.   
Company secretary: J Wolpert                                                    
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
Other Profile Group sites: FundsData Online (unit trust data)  |  Profile Group corporate site
[  Terms of Use |  Privacy Policy |  PAIA manual |  FAQs/Help |  Site Map |  © Copyright Reserved 2026  ]
  


Powered by ProfileData

Profile Mobile App Google Play Store Apple App Store


Follow us on: